AP NEWS

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Welbilt, AxoGen, Markel, and Maxar and Encourages Investors to Contact the Firm

February 10, 2019

NEW YORK, Feb. 10, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C. reminds investors that class action lawsuits have been commenced on behalf of stockholders of Welbilt, Inc., AxoGen, Inc., Markel Corporation, and Maxar Technologies Ltd. Stockholders have until the deadlines listed below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Welbilt, Inc. (NYSE: WBT)

Class Period: February 24, 2017 - November 2, 2018

Lead Plaintiff Deadline: February 11, 2019

The complaint alleges that throughout the class period Welbilt made materially false and/or misleading statements and/or failed to disclose that: (1) the company lacked effective internal control over financial reporting; (2) the company was incorrectly recording the tax basis of foreign subsidiaries and the amortization of their intangible assets; and (3) as a result of the foregoing, defendants’ statements about Welbilt’s business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

To learn more about the Welbilt class action go to: https://bespc.com/wbt/.

AxoGen, Inc. (NASDAQ: AXGN)

Class Period: August 7, 2017 - December 18, 2018

Lead Plaintiff Deadline: March 11, 2019

The complaint alleges that throughout the class period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, the complaint alleges that defendants failed to disclose: (1) that the company aggressively increased prices to mask lower sales; (2) that the company’s pricing alienated customers and threatened the company’s future growth; (3) that ambulatory surgery centers form a significant part of the market for the company’s products; (4) that such centers were especially sensitive to price increases; (5) that the company was dependent on a small number of surgeons whom the company paid to generate sales; (6) that the company’s consignment model for inventory was reasonably likely to lead to channel stuffing; (7) that the company offered purchase incentives to sales representatives to encourage channel stuffing; (8) that the company’s sales representatives were encouraged to backdate revenue to artificially inflate metrics; (9) that the company lacked adequate internal controls to prevent such channel stuffing and backdating of revenue; (10) that the company’s key operating metrics, such as number of active accounts, were overstated; and (11) that, as a result of the foregoing, Defendants’ positive statements about the company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

To learn more about the AxoGen class action go to: http://bespc.com/axgn/.

Markel Corporation (NYSE: MKL)

Class Period: July 26, 2017 - December 6, 2018

Lead Plaintiff Deadline: March 12, 2019

The complaint alleges that throughout the class period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the company’s business, operations, and prospects. Specifically, the complaint alleges that defendants failed to disclose to investors: (1) that the company’s subsidiaries did not appropriately record loss reserves; (2) that, as a result, the loss reserves would need to be adjusted and/or restated; (3) that these misleading accounting practices would lead to regulatory scrutiny and financial loss to investors; and (4) that, as a result of the foregoing, defendant’s positive statements about the company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

To learn more about the Markel class action go to: http://bespc.com/mkl/.

Maxar Technologies Ltd. (NYSE: MAXR)

Class Period: March 29, 2018 - January 7, 2019

Lead Plaintiff Deadline: March 15, 2019

The complaint alleges that throughout the class period defendants made materially false and misleading statements regarding the company’s business, operational, and compliance policies. Specifically, the complaint alleges that defendants made false and/or misleading statements and/or failed to disclose that: (1) Maxar improperly inflated the value of its intangible assets, among other accounting improprieties; (2) Maxar’s highly-valued WorldView-4 was equipped with CMGs that were faulty and/or ill-suited for their designed and intended purpose; and (3) as a result, Maxar’s public statements were materially false and misleading at all relevant times.

To learn more about the Maxar class action go to: http://bespc.com/maxr/.

Bragar Eagel & Squire, P.C. is a New York-based law firm concentrating in commercial and securities litigation. For additional information about Bragar Eagel & Squire, P.C. please go to www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Melissa Fortunato, Esq.(212) 355-4648 investigations@bespc.comwww.bespc.com

AP RADIO
Update hourly